Procter & Gamble Health Ltd.

PGHL

₹5880.5

-0.68% (-40.5)

Market Cap

₹9,830 Cr.

P/E

39.14

Key Ratios

Edit Ratio's

Market cap

9,830 Cr

39.14

Prom Holding

51.82 %

ROE (%)

37.34

ROCE (%)

21.34

Div Yield (%)

2.36

Sales

1,218 Cr

OPM (%)

30.10 %

Debt to Equity

Edit Ratio's

About

Procter & Gamble Health Limited, formerly known as Merck Limited, is a subsidiary of the Merck… Read more

Low

4863

52W Range

High

6176

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Revenue mix

Segment Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Drug Delivery Break-Up

Asset Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Piramal Enterprises Ltd.
Syngene International Ltd.
AGI Greenpac Ltd.
Gulshan Polyols Ltd.
Kilitch Drugs (India) Ltd.
Empire Industries Ltd.
Take Solutions Ltd.
Vivimed Labs Ltd.

Showing 5 of 8

FAQs on Procter & Gamble Health Ltd. Business

What does Procter&Gamble Healt do?

Procter & Gamble Health Limited, formerly Merck Limited, is a leading healthcare company in India that expanded its operations through the acquisition of Merck's Consumer Health business in 2018.

Who are the competitors of Procter&Gamble Healt?

Procter&Gamble Healt major competitors are Strides Pharma Scien, Marksans Pharma, FDC, Sanofi India, Sequent Scientific, Unichem Lab, Natco Pharma.
Market Cap of Procter&Gamble Healt is ₹9,830 Crs.
While the median market cap of its peers are ₹8,291 Crs.

Is Procter&Gamble Healt financially stable compared to its competitors?

Procter&Gamble Healt seems to be less financially stable compared to its competitors.
Altman Z score of Procter&Gamble Healt is 5.57 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Sep Dec	Dec	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Jun		Sep	Sep			Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Apr	Mar Jun Sep Dec
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Procter & Gamble Health Ltd.

Procter & Gamble Health Ltd.

Key Ratios

About

Timeline

Company Timeline

9 Yes

2 Neutral

6 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Promoter Holding

Depreciation Effect

Retail Holding

Revenue Recognition

Price & Performance

Capex vs ROCE

ROE

Share price

Working Capital

Debt

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Sales Growth

Margin Stability

Segment Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Break-Up

UNLOCK PREMIUM

Drug Delivery Break-Up

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

What does Procter&Gamble Healt do?

Who are the competitors of Procter&Gamble Healt?

Is Procter&Gamble Healt financially stable compared to its competitors?

SIGN UP FOR FREE